Zion Medpharma
Endogen (Zion Medpharma) is a São Paulo–based healthtech founded in 2020 that sells prescription medicinal cannabis (under RDC 327/19) and clinical nutrition supplements in Softgel, Veg Caps, and Liquid Capsule formats to patients via a prescriber portal.
- Company typePrivate
- Founded2020
- HeadquartersSão Paulo, Brazil
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Zion Medpharma does
Endogen (legal entity Zion Medpharma) is a Brazil-based healthtech founded in 2020 and headquartered in São Paulo, operating a dual-vertical prescription-driven business across medicinal cannabis and clinical nutrition. The medicinal cannabis line is commercialized under RDC 327/19, Brazil's regulated framework for cannabis-based products, with each batch supported by a Certificate of Analysis; the clinical nutrition line spans Softgel, Veg Caps, and Liquid Capsule delivery formats marketed under the "Endogen Science" sub-brand and manufactured to Swiss pharmaceutical standards.
The company's core commercial infrastructure is its prescriber portal ("Área do Prescritor"), through which licensed physicians order and direct prescription cannabis and nutrition products to patients. This controlled channel is the primary go-to-market mechanism and distinguishes Endogen from retail-channel supplement competitors; there is no disclosed consumer-direct or e-commerce distribution pathway.
Revenue mechanics are prescription-based and sales-led: physicians prescribe, patients purchase, and the company captures the order via the portal. No pricing model, contract value, patient volume, or funding-round data is disclosed in the source material. The company is privately held, reports a headcount of 1–10 employees, and references a LATAM operating scope, although the only confirmed operating geography is Brazil. A co-founder titled "Global Business Development" indicates preparation for cross-border expansion, but no international launch has been disclosed.
Zion Medpharma firmographics
Firmographics- Name
- Zion Medpharma
- Legal name
- Endogen
- Website
- https://zionmedpharma.com.br
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Endogen (Zion Medpharma) is a São Paulo–based healthtech founded in 2020 that sells prescription medicinal cannabis (under RDC 327/19) and clinical nutrition supplements in Softgel, Veg Caps, and Liquid Capsule formats to patients via a prescriber portal.
- Ownership category
- akta.pro rank
Zion Medpharma industry classification
Industry- Product category
- Medicinal Cannabis and Clinical Nutrition
- NAICS
- Pharmacies and Drug Retailers (45611), Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industry
- Medical Cannabis Dispensaries (CRANAFAB)
Keywords
Where Zion Medpharma is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Zion Medpharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Cannabis Products: Prescription-based medical cannabis products regulated under Brazilian RDC 327/19, available exclusively through medical prescriptions
- Clinical Nutrition Supplements: Advanced formulation supplements including Softgel, Veg Caps and Liquid Capsule Technology products for clinical nutrition applications
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Zion Medpharma product offering
Product offeringCore offering
Zion Medpharma (doing business as Endogen) develops and sells prescription-based medicinal cannabis products regulated under Brazilian RDC 327/19 alongside clinical nutrition supplements manufactured to Swiss pharmaceutical standards. Its portfolio covers the Cannabis Medicinal line (medical cannabis with Certificate of Analysis quality control) and the Nutrição Clínica line (Softgel, Veg Caps, and Liquid Capsule encapsulated supplements). All products are dispensed exclusively against medical or nutritional prescription in Brazil.
Product overview
Endogen is a healthtech company offering medicinal cannabis products and clinical nutrition supplements. The product portfolio consists of two core product lines—Cannabis Medicinal and Nutrição Clínica—supported by proprietary encapsulation technologies (Softgel, Veg Caps, and Liquid Capsule Technology). The company operates under Swiss pharmaceutical standards with COA quality control, regulated by Brazilian RDC 327/19. Products are available exclusively via medical or nutritional prescription.
Differentiator
Problem solved
Functional benefit
Products and services
- Cannabis Medicinal Prescription-based medicinal cannabis products regulated under Brazilian RDC 327/19, manufactured to Swiss pharmaceutical standards with Certificate of Analysis (COA) quality control. Available exclusively by medical prescription for patients requiring cannabis-based therapy.
- Nutrição Clínica Clinical nutrition supplements built on advanced formulations with international quality certifications, using Softgel, Veg Caps, and Liquid Capsule Technology to enhance bioavailability and dosage precision. Offered to patients on medical or nutritional prescription.
Companies that use Zion Medpharma
Customer profileSegments2 records
Ideal customer profiles2 records
Zion Medpharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Zion Medpharma partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Zion Medpharma competitors and assessment
Company assessmentRegional players
- JMCC Group: Jamaica-based medical cannabis cultivator and exporter with pharmaceutical-grade operations and international distribution across the Americas. Comparable as a regional player in medical cannabis production targeting regulated international markets.
Broad incumbents
- Aurora Cannabis Inc. Major Canadian cannabis company with global medical cannabis distribution and pharmaceutical-grade product capabilities. Comparable as a broad incumbent operating in regulated medical cannabis markets internationally.
- Canopy Growth Corporation: Major Canadian-headquartered cannabis company with international medical cannabis operations including Latin America. Comparable as a broad incumbent serving medical cannabis patients in regulated markets with pharmaceutical-grade products.
- OrganiGram Holdings Inc. Canadian cannabis producer with a focus on pharmaceutical-grade dried flower and extracted products for medical markets. Comparable as a broad incumbent in regulated medical cannabis markets with quality-certified production.
- Cronos Group Inc. Canadian cannabis operator with international medical cannabis footprint and branded cannabinoid product portfolio. Comparable as a broad incumbent in regulated medical cannabis with international distribution capabilities.
- Tilray Brands, Inc. Global cannabis leader with established Brazilian medical cannabis operations and broad product portfolio. Comparable as a major incumbent that competes with Endogen in the Brazilian prescription medical cannabis market but at much greater scale and geographic reach.
Direct peers
- Entourage Phytolab: Brazilian cannabis company focused on scientific research and development of cannabinoid-based therapies. Directly comparable as a Brazil-based medical cannabis operator with a research-driven approach serving prescribers and patients.
- Khiron Life Sciences Corp. Latin American medical cannabis company with operations in Colombia and Brazil. Directly comparable as a prescription-based medical cannabis operator in Brazil under similar regulatory frameworks, serving physicians and patients with cannabinoid therapies.
- Clever Leaves Holdings Inc. Colombian-headquartered cannabis cultivator and manufacturer serving LATAM and international markets with pharmaceutical-grade cannabinoid products. Comparable as a LATAM medical cannabis producer supplying regulated markets under pharmaceutical standards.
Emerging players
- MediPharm Labs Corp. Canadian cannabis extract specialist focused on pharmaceutical-grade cannabinoid formulations for medical and consumer markets. Comparable as a niche producer focused on cannabis extraction and formulation technology similar to Endogen's cannabis oil extraction focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Zion Medpharma compliance and trust
Trust signalCompliance2 records
Zion Medpharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zion Medpharma leadership team
Management profileNumber of profiles
Profiles1 record
Zion Medpharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zion Medpharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zion Medpharma
What does Zion Medpharma do?
Zion Medpharma (doing business as Endogen) develops and sells prescription-based medicinal cannabis products regulated under Brazilian RDC 327/19 alongside clinical nutrition supplements manufactured to Swiss pharmaceutical standards. Its portfolio covers the Cannabis Medicinal line (medical cannabis with Certificate of Analysis quality control) and the Nutrição Clínica line (Softgel, Veg Caps, and Liquid Capsule encapsulated supplements). All products are dispensed exclusively against medical or nutritional prescription in Brazil.
Is Zion Medpharma a public or private company?
Zion Medpharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Zion Medpharma founded?
Zion Medpharma was founded in 2020. It employs 1 to 10 people.
Where is Zion Medpharma based?
Zion Medpharma is headquartered in São Paulo, Brazil, in the Latin America region.
How does Zion Medpharma make money?
Two revenue lines are on record. Medical Cannabis Products are the primary driver. The others are clinical Nutrition Supplements.
Who are Zion Medpharma's main competitors?
JMCC Group is listed as a regional player. Broad incumbents are Aurora Cannabis Inc., Canopy Growth Corporation, OrganiGram Holdings Inc., Cronos Group Inc. and Tilray Brands, Inc.. Direct peers are Entourage Phytolab, Khiron Life Sciences Corp. and Clever Leaves Holdings Inc.. MediPharm Labs Corp. is listed as an emerging player.
Does Zion Medpharma have an API?
No public API is recorded for Zion Medpharma.
What industry is Zion Medpharma in?
Zion Medpharma's product category is Medicinal Cannabis and Clinical Nutrition. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 45611 and its SIC code is 2834.